- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Shrink Nanotechnologies Enters into Technology Integration and Development Agreement With Lydall, Inc. Solutech BV for Solupore® Plastic Membrane
Under the terms of the agreement, Lydall Solutech, a Lydall, Inc. (NYSE: LDL) company, will provide Shrink with certain quantities of its Solupore® thermoplastic membrane for the purpose of conducting a one-year research and development project. The goal of the project is to develop a robust, ultra-rapid diagnostic platform that increases the sensitivity of fluorescent-based assays by integrating Solupore technology with Shrink's rapid prototyping system, ShrinkChip Manufacturing System™ and NanoPetal™ technology. Under the terms of the agreement, any ownership of new intellectual property will bebased on inventorship.
Mark L. Baum, CEO of Shrink Nanotechnologies, stated, "This new relationship with Lydall Solutech is part of our effort to turn our NanoShrink materials into viable systems used in critical point-of-care and point-of-operations products. The market for these types of sensors is in the billions of US Dollars in annual sales, and they are used in a wide range of commercial applications such as food safety, personalized drug therapies and disease screening, to name a few. By producing more of the overall system solution, with the integration of the Lydall Solutech Solupore® material, we seek to increase the flexibility and scope of these important diagnostic devices and in turn open the door to future strategic partnerships with leading research laboratories in industry and academia."
For more information, please click here
Phone: (760) 804-8844
Fax: (760) 804-8845
Copyright © Shrink NanotechnologiesIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016
Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016
NIST Patents Single-Photon Detector for Potential Encryption and Sensing Apps September 16th, 2016
Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016